ASTELLAS PHARMA INC. Patent Application Trends in 2024
Jump to navigation
Jump to search
Contents
ASTELLAS PHARMA INC. Patent Filing Activity
ASTELLAS PHARMA INC. patent applications in 2024
Top 10 Technology Areas
- A61P35/00 (Antineoplastic agents)
- Count: 7 patents
- Example: 20240101532. HETEROARYL CARBOXAMIDE COMPOUND simplified abstract (Astellas Pharma Inc.)
- C07K16/28 (PEPTIDES (peptides in foodstuffs)
- A61K2039/505 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
- C07K2317/31 (PEPTIDES (peptides in foodstuffs)
- Count: 4 patents
- Example: 20240209079. ANTIBODIES USEFUL IN CANCER DIAGNOSIS simplified abstract (Astellas Pharma Inc.)
- C07D401/12 (HETEROCYCLIC COMPOUNDS (macromolecular compounds)
- Count: 3 patents
- Example: 20240101532. HETEROARYL CARBOXAMIDE COMPOUND simplified abstract (Astellas Pharma Inc.)
- A61K31/519 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
- Count: 3 patents
- Example: 20240101532. HETEROARYL CARBOXAMIDE COMPOUND simplified abstract (Astellas Pharma Inc.)
- C07D403/12 (HETEROCYCLIC COMPOUNDS (macromolecular compounds)
- Count: 3 patents
- Example: 20240101532. HETEROARYL CARBOXAMIDE COMPOUND simplified abstract (Astellas Pharma Inc.)
- A61K45/06 (Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca)
- A61K31/454 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
- Count: 2 patents
- Example: 20240101532. HETEROARYL CARBOXAMIDE COMPOUND simplified abstract (Astellas Pharma Inc.)
- A61K31/4545 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
- Count: 2 patents
- Example: 20240101532. HETEROARYL CARBOXAMIDE COMPOUND simplified abstract (Astellas Pharma Inc.)
Emerging Technology Areas
- C12N2310/11 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media)
- C12N9/78 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media)
- C12N15/113 (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants)
- C07D519/00 (HETEROCYCLIC COMPOUNDS (macromolecular compounds)
- Count: 1 patents
- Example: 20240150366. 4-AMINOQUINAZOLINE COMPOUND simplified abstract (Astellas Pharma Inc.)
- C12Q2600/156 (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay)
- C12Q2600/118 (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay)
- A61K47/6801 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
- C12Q1/6883 (for diseases caused by alterations of genetic material)
- C12Q1/6886 (for cancer (immunoassay for cancer)
- C07K2319/00 (PEPTIDES (peptides in foodstuffs)
Top Inventors
- Takuya Washio (3 patents)
- Hiroshi Tomiyama (3 patents)
- Akihiko Nakamura (3 patents)
- Ugur Sahin (3 patents)
- Makoto OGINO (3 patents)
- Hideyuki Watanabe (2 patents)
- Takashi Kamikubo (2 patents)
- Akio Kamikawa (2 patents)
- Yohei Seki (2 patents)
- Keiichiro Okuyama (2 patents)
Patent Categories
Geographical Distribution of Inventors
Geographical Distribution of US Inventors
Categories:
- ASTELLAS PHARMA INC.
- Companies
- CPC C07D401/12
- CPC A61K31/454
- CPC A61K31/4545
- CPC A61K31/496
- CPC A61K31/501
- CPC A61K31/519
- CPC A61P35/00
- CPC C07D401/14
- CPC C07D403/12
- CPC C07D403/14
- CPC C07D405/14
- CPC C07D413/04
- CPC C07D413/14
- CPC C07D487/04
- CPC C07K16/18
- CPC A61K39/3955
- CPC A61K45/06
- CPC A61K47/6803
- CPC A61K47/6807
- CPC A61K47/6809
- CPC A61K47/6813
- CPC A61K47/6821
- CPC A61K47/6823
- CPC A61K47/6829
- CPC A61K47/6851
- CPC A61K47/6859
- CPC A61K47/6863
- CPC A61K47/6869
- CPC A61K51/1063
- CPC C07K16/28
- CPC C07K16/3046
- CPC A61K2039/505
- CPC C07K2317/73
- CPC C07K2317/732
- CPC C07K2317/734
- CPC A61K49/0034
- CPC A61K9/0014
- CPC A61K9/0034
- CPC A61K49/0054
- CPC C07D487/08
- CPC C12N5/0661
- CPC A61K35/44
- CPC A61P7/00
- CPC C07K14/503
- CPC C12N5/10
- CPC A61K31/513
- CPC A61K31/555
- CPC A61K31/7068
- CPC A61K2039/507
- CPC A61B5/024
- CPC A61B5/0077
- CPC A61B5/7275
- CPC A61K31/4166
- CPC A61K47/6849
- CPC G01N33/57492
- CPC C07K2317/21
- CPC C07K2317/24
- CPC C07K2317/31
- CPC C07K2317/34
- CPC C07K16/2878
- CPC C07K2317/622
- CPC C07D253/07
- CPC C07D211/56
- CPC C07D405/12
- CPC C07D407/14
- CPC C07D409/12
- CPC C07D413/12
- CPC C07F5/027
- CPC G16H50/20
- CPC G16H10/20
- CPC G16H10/60
- CPC G16H50/70
- CPC A61B5/355
- CPC A61B5/366
- CPC A61B5/361
- CPC A61B5/7267
- CPC C07K16/2809
- CPC C07K2317/40
- CPC C07K2317/52
- CPC C07K2317/55
- CPC C07K2317/76
- CPC A61K38/2013
- CPC A61K39/39558
- CPC C07K16/30
- CPC C07K16/303
- CPC C07K16/2863
- CPC A61K39/395
- CPC C07K2319/00
- CPC C12Q1/6886
- CPC C12Q1/6883
- CPC A61K47/6801
- CPC C12Q2600/118
- CPC C12Q2600/156
- CPC C07D519/00
- CPC C12N15/113
- CPC C12N9/78
- CPC C12N2310/11
- Patent Trends by Company in 2024
